Jacobson A E, Harrison E A, Mattson M V, Rafferty M F, Rice K C, Woods J H, Winger G, Solomon R E, Lessor R A, Silverton J V
Laboratory of Neuroscience, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
J Pharmacol Exp Ther. 1987 Oct;243(1):110-7.
Dioxadrol exists in four isomeric forms. alpha-(+)-Dioxadrol (dexoxadrol) showed phencyclidine (PCP)-like activity in rhesus monkeys trained to discriminate s.c. administration of ketamine, but neither alpha-(-)-dioxadrol (levoxadrol) nor beta-(+/-)-dioxadrol showed such activity. In addition, response-contingent i.v. dexoxadrol maintained higher rates of responding than either levoxadrol or beta-dioxadrol in monkeys experienced with ketamine self-administration. The order of potency in displacing bound 1-[1-(2-thienyl)cyclohexyl]piperidine from binding sites in rat brain homogenates was dexoxadrol much greater than levoxadrol = beta-(+/-)-dioxadrol. Viewed in the context of previous studies with stereochemical probes of the PCP receptor, these results extend and confirm the supposition that dexoxadrol and levoxadrol are the stereochemical probes of choice in the study of effects mediated through PCP receptors. The absolute configuration of dexoxadrol was determined to be 4S, 6S by X-ray crystallography, thus defining the optimum chirality necessary for receptor binding and PCP-like activity in the dioxadrol series. Based on these and other considerations, receptor-active conformations of dexoxadrol and PCP are proposed.
二氧卓醇存在四种异构体形式。α-(+)-二氧卓醇(右旋氧卓醇)在经训练可辨别皮下注射氯胺酮的恒河猴中表现出苯环己哌啶(PCP)样活性,但α-(-)-二氧卓醇(左旋氧卓醇)和β-(+/-)-二氧卓醇均未表现出此类活性。此外,在经历氯胺酮自我给药的猴子中,静脉注射右旋氧卓醇后反应率高于左旋氧卓醇或β-二氧卓醇。在大鼠脑匀浆中从结合位点置换结合的1-[1-(2-噻吩基)环己基]哌啶的效力顺序为:右旋氧卓醇远大于左旋氧卓醇 = β-(+/-)-二氧卓醇。结合之前使用PCP受体立体化学探针的研究来看,这些结果扩展并证实了如下推测:右旋氧卓醇和左旋氧卓醇是研究通过PCP受体介导的效应时的首选立体化学探针。通过X射线晶体学确定右旋氧卓醇的绝对构型为4S, 6S,从而确定了二氧卓醇系列中受体结合和PCP样活性所需的最佳手性。基于这些及其他考虑因素,提出了右旋氧卓醇和PCP的受体活性构象。